Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Klocker

Showing results (111-120 of 142) with videos related to

Pageof 15
Sort By:
The Journal of Pathology|July 1, 1997
Metastatic lesions from prostate cancer do not express oestrogen and progesterone receptorsA Hobisch, A Hittmair, G Daxenbichler, et al.
In Vitro Cellular & Developmental Biology. Animal|February 18, 1998
A reliable system for the culture of human prostatic cellsM V Cronauer, I E Eder, A Hittmair, et al.
European Journal of Cell Biology|October 1, 1987
Isolation of a cDNA clone for human NAD+: protein ADP-ribosyltransferaseR Schneider, B Auer, C Kühne, et al.
Cancer Gene Therapy|August 5, 2000
Inhibition of LncaP prostate cancer cells by means of androgen receptor antisense oligonucleotidesI E Eder, Z Culig, R Ramoner, et al.
World Journal of Urology|December 29, 2000
Selective culture conditions for different types of primary human bladder cellsI E Eder, S Corvin, C Maneschg, et al.
Molecular Endocrinology (Baltimore, Md.)|December 1, 1993
Mutant androgen receptor detected in an advanced-stage prostatic carcinoma is activated by adrenal androgens and progesteroneZ Culig, A Hobisch, M V Cronauer, et al.
Scandinavian Journal of Urology and Nephrology. Supplementum|January 1, 1994
Cytogenetics of prostate cancer. Consensus Conference on Diagnosis and Prognostic Parameters in Localized Prostate Cancer. Stockholm, Sweden, May 12-13, 1993F M Debruyne, V P Collins, H van Dekken, et al.
The Journal of Urology|February 18, 1999
Cellular and humoral immune responses in patients with metastatic renal cell carcinoma after vaccination with antigen pulsed dendritic cellsL Höltl, C Rieser, C Papesh, et al.
Urology|December 1, 1996
Usefulness of the ratio free/total prostate-specific antigen in addition to total PSA levels in prostate cancer screeningA Reissigl, H Klocker, J Pointner, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|July 1, 1995
In vivo LDL receptor and HMG-CoA reductase regulation in human lymphocytes and its alterations during agingT M Stulnig, H Klocker, H J Harwood, et al.
Pageof 15

Showing results (111-120 of 142) with videos related to

Sort By:
Pageof 15
The Journal of Pathology|July 1, 1997
Metastatic lesions from prostate cancer do not express oestrogen and progesterone receptorsA Hobisch, A Hittmair, G Daxenbichler, et al.
In Vitro Cellular & Developmental Biology. Animal|February 18, 1998
A reliable system for the culture of human prostatic cellsM V Cronauer, I E Eder, A Hittmair, et al.
European Journal of Cell Biology|October 1, 1987
Isolation of a cDNA clone for human NAD+: protein ADP-ribosyltransferaseR Schneider, B Auer, C Kühne, et al.
Cancer Gene Therapy|August 5, 2000
Inhibition of LncaP prostate cancer cells by means of androgen receptor antisense oligonucleotidesI E Eder, Z Culig, R Ramoner, et al.
World Journal of Urology|December 29, 2000
Selective culture conditions for different types of primary human bladder cellsI E Eder, S Corvin, C Maneschg, et al.
Molecular Endocrinology (Baltimore, Md.)|December 1, 1993
Mutant androgen receptor detected in an advanced-stage prostatic carcinoma is activated by adrenal androgens and progesteroneZ Culig, A Hobisch, M V Cronauer, et al.
Scandinavian Journal of Urology and Nephrology. Supplementum|January 1, 1994
Cytogenetics of prostate cancer. Consensus Conference on Diagnosis and Prognostic Parameters in Localized Prostate Cancer. Stockholm, Sweden, May 12-13, 1993F M Debruyne, V P Collins, H van Dekken, et al.
The Journal of Urology|February 18, 1999
Cellular and humoral immune responses in patients with metastatic renal cell carcinoma after vaccination with antigen pulsed dendritic cellsL Höltl, C Rieser, C Papesh, et al.
Urology|December 1, 1996
Usefulness of the ratio free/total prostate-specific antigen in addition to total PSA levels in prostate cancer screeningA Reissigl, H Klocker, J Pointner, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|July 1, 1995
In vivo LDL receptor and HMG-CoA reductase regulation in human lymphocytes and its alterations during agingT M Stulnig, H Klocker, H J Harwood, et al.
Pageof 15